million
case
malaria
year
worldwide
causing
one
million
death
around
death
occur
africa
mostly
young
child
one
greatest
challenge
facing
africa
fight
malaria
drug
resistance
resistance
chloroquine
cq
cheapest
widely
used
antimalarial
common
throughout
africa
resistance
sp
least
expensive
alternative
cq
also
increasing
eastern
southern
africa
trend
forced
many
country
change
treatment
policy
use
expensive
drug
including
drug
combination
hopefully
slow
development
resistance
one
avenue
research
identify
combination
minimize
gametocyte
emergence
treated
case
prevent
selective
transmission
parasite
resistant
partner
drug
month
plo
medicine
colin
sutherland
colleague
tested
two
leading
combination
therapy
child
uncomplicated
malaria
one
regimen
combination
consisting
artemether
lumefantrine
trade
name
coartem
riamet
combination
cq
consideration
several
african
country
largely
due
low
cost
randomized
controlled
trial
child
acute
uncomplicated
falciparum
malaria
given
either
combination
cq
sp
six
dos
received
received
blood
tested
infectivity
mosquito
seven
day
treatment
follow
seven
day
team
found
child
treated
significantly
le
likely
carry
gametocyte
blood
child
treated
cq
compared
altogether
regimen
highly
effective
reducing
prevalence
duration
gametocyte
carriage
number
gametocyte
infectiousness
mosquito
day
also
reduced
compared
combination
cq
sp
said
author
study
already
shown
potential
combination
therapy
cure
malaria
reduce
gametocyte
carriage
acknowledged
author
however
study
first
demonstrate
treatment
potential
markedly
reduce
infectiousness
patient
mosquito
done
african
setting
highly
seasonal
transmission
asymptomatic
infection
common
result
mean
introduced
treatment
malaria
africa
author
hesitant
suggest
might
compliance
issue
regimen
requirement
oily
food
adequate
absorption
might
also
lead
inadequate
drug
level
blood
many
treated
individual
author
suggest
treatment
likely
reduce
overall
transmission
plasmodium
falciparum
within
community
rather
would
reduce
selective
transmission
resistant
parasite
treated
patient
hence
could
public
health
benefit
reducing
impact
drug
resistance